Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes
Authors:
Open Access
- 31 May 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 20 (5) , e3001643
Abstract
Ensuring high vaccination and even booster vaccination coverage is critical in preventing severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines currently in use, the mRNA vaccines have shown remarkable effectiveness. However, systemic adverse events (AEs), such as postvaccination fatigue, are prevalent following mRNA vaccination, and the underpinnings of which are not understood. Herein, we found that higher baseline expression of genes related to T and NK cell exhaustion and suppression were positively correlated with the development of moderately severe fatigue after Pfizer-BioNTech BNT162b2 vaccination; increased expression of genes associated with T and NK cell exhaustion and suppression reacted to vaccination were associated with greater levels of innate immune activation at 1 day postvaccination. We further found, in a mouse model, that altering the route of vaccination from intramuscular (i.m.) to subcutaneous (s.c.) could lessen the pro-inflammatory response and correspondingly the extent of systemic AEs; the humoral immune response to BNT162b2 vaccination was not compromised. Instead, it is possible that the s.c. route could improve cytotoxic CD8 T-cell responses to BNT162b2 vaccination. Our findings thus provide a glimpse of the molecular basis of postvaccination fatigue from mRNA vaccination and suggest a readily translatable solution to minimize systemic AEs.Keywords
Funding Information
- National Medical Research Council (OFLCG19May-0034)
- National Medical Research Council (MOH-000135-00)
- National Medical Research Council (MOH-OFYIRG18nov-0004)
This publication has 48 references indexed in Scilit:
- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus MacaquesMolecular Therapy, 2017
- Early molecular correlates of adverse events following yellow fever vaccinationJCI Insight, 2017
- Knowledge and Attitudes towards Complementary and Alternative Medicine among Senior Medical Students in King Abdulaziz University, Saudi ArabiaEvidence-Based Complementary and Alternative Medicine, 2016
- Molecular signatures of antibody responses derived from a systems biology study of five human vaccinesNature Immunology, 2013
- Natural killer cells in patients with severe chronic fatigue syndromeAutoimmunity Highlights, 2013
- NKp80 defines and stimulates a reactive subset of CD8 T cellsBlood, 2009
- Adaptive immune cells temper initial innate responsesNature Medicine, 2007
- The Role of CD94/NKG2 in Innate and Adaptive ImmunityImmunologic Research, 2004
- Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cellsSeminars in Immunology, 2000
- HumanKLRF1, a novel member of the killer cell lectin-like receptor gene family: molecular characterization, genomic structure, physical mapping to the NK gene complex and expression analysisEuropean Journal of Immunology, 2000